CEO Michael Patrick Lyons highlighted a strong quarter, stating, "we grew sales, clients and our new business pipeline. We announced several exciting new partnerships and acquisitions, introduced ...
The company maintained its 2025 guidance of 10%-12% organic revenue growth and adjusted EPS of $10.10-$10.30, representing 15%-17% growth. Merchant Solutions organic ...
Clover Health (CLOV) reported its second consecutive profitable quarter with $478M in revenue and $17M adjusted EBITDA, beating expectations for the fifth straight quarter. Medicare Advantage ...
Clover Health Investments Corp (CLOV) reported its fourth-quarter earnings for 2025, revealing a revenue of $487.2 million, surpassing expectations by 4.31%. The company’s earnings per share (EPS) ...